At Carolinas HealthCare System’s Levine Cancer Institute, our Hematologic Oncology and Blood Disorders program includes more than a dozen nationally recruited specialists dedicated to treating blood disorders and blood cancers. Subspecialists provide care in specific malignancies, including:
For more information about Levine Cancer Institute, call 980-442-2000.
Our blood and marrow transplant program provides access to the highest quality of care in the area of transplantation. Our program is a specialized center for matched, related and haploidentical transplants with a comprehensive quality management program, advanced cell processing laboratory and a stem cell collection unit. Our state-of-the-art blood and marrow transplant (BMT) unit is the first to be built in the region.
Specially trained in bone marrow and blood transplantation, our team provides innovative and supportive care to adults with hematologic malignancies in need of blood or marrow transplantation.
Our physicians are subspecialized in hematologic malignancies and transplantation and work with other consulting physicians in infectious diseases, dermatology, pulmonary medicine and surgeons who have extensive experience in transplantation.
Our leukemia program offers comprehensive care for patients with acute and chronic leukemias, as well as myelodysplastic syndromes and myeloproliferative neoplasms.
We strive to provide the highest quality of patient care, utilizing leading-edge therapies, including clinical trials. Our patients are cared for in state-of-the-art inpatient and outpatient facilities, located across the Carolinas.
Our physicians are preeminent experts in leukemia and related conditions, recruited from the world’s top medical institutions. They work closely with a team of experienced pharmacists, advanced care practitioners, clinical and research nurses, social workers and patient navigators.
Our leukemia program is also supported by a dedicated hematopathology team, based on-site at Carolinas Medical Center in Charlotte, NC.
In conjunction with our active clinical research program, we have also assembled an expert team of laboratory scientists in the Cannon Research Center. Our objective is to advance the care of leukemia, with the goal of more effective, less-toxic therapies for patients.
There are more than 20 types of lymphomas, each requiring a different approach to treatment. Our team of top academic physicians develops innovative and individualized treatment plans designed to give each patient the best possible outcome.
Your care will involve the best standard treatments currently available, as well as access to new therapies and clinical trials based on leading-edge research in the field of lymphoma treatment.
There are several types of plasma disorders, including multiple myeloma, Waldenstrom's macroglubulinemia and systemic amyloidosis.
The focus of our plasma cell disorders program is to lead the field of the treatment regimens and protocols for patients with multiple myeloma and other plasma cell disorders. Our program focuses on bringing advances in research and treatment options to our patients.
The Hematologic Oncology and Blood Disorders program places special emphasis on clinical trials. Our physicians participate in national clinical research studies that test novel technologies and treatments, allowing families to stay close to home to access the best care.
The cancer care process can feel confusing and overwhelming at times – often involving physical, financial and emotional challenges for you and your family. From diagnosis to survivorship, we have numerous resources available to support you during your treatment experience.